Structure-Based Design of a Potent, Selective, and Irreversible Inhibitor of the Catalytic Domain of the erbB Receptor Subfamily of Protein Tyrosine Kinases (Q56552583)
article by Juswinder Singh et al published March 1997 in Journal of Medicinal Chemistry
Language:
Current Data About Structure-Based Design of a Potent, Selective, and Irreversible Inhibitor of the Catalytic Domain of the erbB Receptor Subfamily of Protein Tyrosine Kinases
(P31) (Q13442814)

(P304) 1130-1135

(P407) (Q1860)

(P433) 7

(P478) 40

(P577) +1997-03-00T00:00:00Z

(P921) (Q735188)

(P1433) (Q900316)

(P1476) "Structure-Based Design of a Potent, Selective, and Irreversible Inhibitor of the Catalytic Domain of the erbB Receptor Subfamily of Protein Tyrosine Kinases" (language: en)

(P2093) Juswinder Singh
(P1545) 1

Ellen M. Dobrusin
(P1545) 2

David W. Fry
(P1545) 3

Taraneh Haske
(P1545) 4

Adrian Whitty
(P1545) 5

Dennis J. McNamara
(P1545) 6

(P2860) (Q27860989)
(P248)
(P854) https://opencitations.net/index/coci/api/v1/citations/10.1016/S0022-2836(77)80200-3
(P813) Sunday, March 5, 2023

other details
description article by Juswinder Singh et al published March 1997 in Journal of Medicinal Chemistry

External Links
(P356) 10.1021/JM960380S
(P698) 9089334